Related Experiment Video
Updated: May 7, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene
Liping Dou1, Jingxin Li, Dehua Zheng
1Department of Hematology, Chinese PLA General Hospital, Fuxing Road 28th, Beijing, 100853, China.
Abstract:
The mixed-lineage leukemia (MLL)-AF4 fusion protein encoded by the chromosomal translocation t(4;11) predicts a poorer prognosis in acute lymphoblastic leukemia (ALL) than in other MLL-associated leukemias. However, the detailed mechanism underlying regulation of MLL-AF4 expression remains largely unknown. In this study, we showed that microRNA (miR)-142-3p was significantly downregulated in ALL patients expressing MLL-AF4. Upregulation of miR-142-3p decreased MLL-AF4 expression in the RS4;11 leukemic cell line, which suggests that MLL-AF4 is a direct target of miR-142-3p. Ectopic expression of miR-142-3p remarkably suppressed cell proliferation and induced apoptosis in RS4;11 cells expressing the MLL-AF4 fusion protein. We also found that exogenous expression of miR-142-3p strongly reduced the expression of MLL-AF4 target genes such as homeobox A (HOXA)9, HOXA7, and HOXA10 in RS4;11 cells. Taken together, our results indicate that miR-142-3p functions as a growth suppressor in MLL-AF4(+) ALL, and its suppressive effects are mediated primarily through repression of MLL-AF4 expression.
Insights
MicroRNA-142-3p acts as a tumor suppressor in acute lymphoblastic leukemia (ALL) with the MLL-AF4 fusion protein. Upregulating this microRNA inhibits cancer cell growth and promotes cell death by targeting MLL-AF4.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The MLL-AF4 fusion protein, resulting from t(4;11) translocation, is associated with poor prognosis in acute lymphoblastic leukemia (ALL).
- Mechanisms regulating MLL-AF4 expression in ALL are not fully understood.
Purpose of the Study:
- To investigate the role of microRNA-142-3p (miR-142-3p) in the regulation of MLL-AF4 expression in ALL.
- To determine the functional impact of miR-142-3p on MLL-AF4-positive ALL cells.
Main Methods:
- Quantitative analysis of miR-142-3p levels in ALL patients.
- In vitro experiments using the RS4;11 leukemic cell line to assess the effects of miR-142-3p modulation on MLL-AF4 expression, cell proliferation, and apoptosis.
- Analysis of MLL-AF4 target gene expression.
Main Results:
- miR-142-3p was significantly downregulated in ALL patients with MLL-AF4.
- Upregulation of miR-142-3p in RS4;11 cells reduced MLL-AF4 expression, suppressed proliferation, and induced apoptosis.
- miR-142-3p directly targets MLL-AF4 and represses its downstream targets, including HOXA9, HOXA7, and HOXA10.
Conclusions:
- miR-142-3p functions as a tumor suppressor in MLL-AF4-positive ALL.
- The growth-suppressive effects of miR-142-3p are primarily mediated by the repression of MLL-AF4 expression and its target genes.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
